ABDULLAYEV, E. Et Al. 2019. IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective, single-center experience (PIGMENT study). 30th Annual Meeting of the European Society of Paediatric and Neonatal Intensive Care .

ABDULLAYEV, E., KILIÇ, Ö., BOZAN, G., KIRAL, E., İŞERİ NEPESOV, M., & DİNLEYİCİ, E. Ç., (2019). IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective, single-center experience (PIGMENT study) . 30th Annual Meeting of the European Society of Paediatric and Neonatal Intensive Care

ABDULLAYEV, EMİN Et Al. "IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective, single-center experience (PIGMENT study)," 30th Annual Meeting of the European Society of Paediatric and Neonatal Intensive Care, 2019

ABDULLAYEV, EMİN Et Al. "IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective, single-center experience (PIGMENT study)." 30th Annual Meeting of the European Society of Paediatric and Neonatal Intensive Care , 2019

ABDULLAYEV, E. Et Al. (2019) . "IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective, single-center experience (PIGMENT study)." 30th Annual Meeting of the European Society of Paediatric and Neonatal Intensive Care .

@conferencepaper{conferencepaper, author={EMİN ABDULLAYEV Et Al. }, title={IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective, single-center experience (PIGMENT study)}, congress name={30th Annual Meeting of the European Society of Paediatric and Neonatal Intensive Care}, city={}, country={}, year={2019}}